Objective: This review examines the evidence from head-to-head randomised controlled trials addressing whether the efficacy of cognitive-behavioural therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorders in adults delivered by computer or online (computer-and Internet-delivered cognitive-behavioural therapy) is not inferior to in-person cognitive-behavioural therapy for reducing levels of symptoms and producing clinically significant gains at post-treatment and at follow-up. A supplementary aim is to examine the evidence for severity as a moderator of the relative efficacy of computer-and Internet-delivered cognitive-behavioural therapy and in-person cognitive-behavioural therapy.
Introduction
Mental disorders which are characterised by excessive anxiety either as persistent anxious apprehension or as frequent experiences of acute fear, make up a large proportion of mental health presentation in primary care and carry one of the highest burden of all mental health disorders (Whiteford et al., 2013) . These disorders are classified into three broad domains (anxiety disorders, trauma-and stressor-related disorders, obsessive-compulsive and related disorders; Diagnostic and Statistical Manual of Mental Disorders [5th ed.; ; American Psychiatric Association [APA], 2013) depending on the nature of the behavioural changes, physical difficulties and cognitive manifestations which accompany the excessive anxiety and fear. While they have distinctive features, there is good evidence that these disorders have common vulnerabilities and share underlying pathological processes which explain how the maladaptive regulation of anxiety and fear develops and is maintained (Barlow, 2002; Brown et al., 2001; Suarez et al., 2009) . Cognitive-behavioural therapy (CBT) attempts to alter these underlying maintenance processes and reduce the ongoing influence of the vulnerabilities. Consistent evidence shows that CBT for fear-based anxiety disorders, post-traumatic stress disorders (PTSD) and obsessivecompulsive disorder (OCD) is superior at post-treatment to credible psychological placebos, pill placebos, care-asusual (CAU) and waitlist comparators (Carpenter et al., 2018; Cuijpers et al., 2016) . It is considered a first-line treatment (American Academy of Child and Adolescent Psychiatry [AACAP], 2012; APA, 2009 ; National Institute for Health and Clinical Excellence [NICE], 2005) and is recommended in preference to medication or to optimise treatment response when combined with medication for some disorders (March et al., 2004; Turner et al., 2018) .
These conclusions and recommendations are based on evidence for CBT when delivered in a format where the therapist meets in person with the patient to work through the various components of the therapy. The last few decades have seen a rapid growth in the development of new delivery formats for CBT, in particular the use of computers and the Internet (Firth et al., 2016) . Recent clinical practice guidelines for the treatment of anxiety disorders (Andrews et al., 2018a) support the use of digital delivery of CBT and claims that it 'appears to be equally beneficial' (Andrews et al., 2018b: 119) compared with CBT with a therapist. While there is evidence that computer-and Internet-delivered CBT (c/iCBT) for anxiety disorders is superior to the passage of time (waitlist control) and some active controls (CAU) in randomised controlled trials (RCTs; Andersson et al., 2014; Carlbring et al., 2018) , an essential test for the efficacy of a new treatment or new version of an existing efficacious treatment is how it compares to the established best standard of care, that is, inperson CBT. Unless there are reasons to believe c/iCBT is superior to in-person CBT, studies need to ask if there is evidence that the benefits of c/iCBT are not inferior to the benefits of in-person CBT to a degree more than is offset by any advantages it confers. In other words, the observed relative benefits of in-person CBT over c/iCBT should not be greater than an allowable loss of efficacy for c/iCBT because it may, for example, be more easily accessible, reduce costs or be a better platform for help-seeking for those wanting to preserve their anonymity or to minimise stigma. This allowable loss of efficacy for c/iCBT (noninferiority margin) sets the limits that if not exceeded establishes c/iCBT to be not inferior to in-person CBT (Schumi and Wittes, 2011) .
Existing reviews of the efficacy of c/iCBT for anxiety disorders, PTSD and OCD, which have included c/iCBT compared with in-person CBT outcomes (Andersson et al., 2014; Andrews et al., 2018a; Arnberg et al., 2014; Carlbring et al., 2018) , are questionable in regard to the conclusion that c/iCBT is not inferior to in-person CBT. Most notably, they rarely consider study design recommended for testing non-inferiority (CONSORT Criteria Extension for noninferiority and equivalence randomised trials; Piaggio et al., 2012) . These criteria include prior specification of the non-inferiority margin, a test of the efficacy of the active comparator and estimating sample size for a noninferiority hypothesis and use of a range of trial analyses (per-protocol, intention-to-treat [ITT] ). To date, reviews have assessed risk of bias in the included studies as if they aimed to identify treatment superiority and do not evaluate any risk of bias of the studies in respect to inferring noninferiority. Many reviews (Andrews et al., 2018a; Carlbring et al., 2018) also draw the erroneous conclusion that inferiority or equivalence of c/iCBT compared with in-person CBT is established or indicated because the pooled estimate of the between-group effect (c/iCBT vs in-person CBT) is not significantly different from zero or its 95% confidence interval (CI) crosses zero. It is a misinterpretation to conclude that a failure to find evidence for a difference between two treatments in a trial is evidence that the treatments are equivalent or that the new treatment is not inferior to the comparator (Altman and Bland, 1995; Greene et al., 2008; Piaggio et al., 2012) . None of the previous reviews have tested the pooled relative treatments effects using a non-inferiority hypothesis and against a non-inferiority margin. Using proper study designs for assessing noninferiority protects against the widespread acceptance and dissemination of a new treatment or treatment format which lowers benefits to patients (Rief and Hofman, 2018) . Therefore, it is as important to apply these designs when evaluating a new psychosocial treatment for a mental disorder as for any new medication (Greene et al., 2008) .
This study uses systematic review methodology to address these limitations by identifying all studies comparing in-person CBT to c/iCBT for anxiety disorders, PTSD and OCD and applying risks of bias criteria relevant for inferring non-inferiority to identified studies. In addition, it assesses the strength of the c/iCBT compared with in-person CBT effects against the non-inferiority hypothesis, H 0 : μ (in-person CBT) -μ (c/iCBT) ⩾ Δ, where Δ = noninferiority margin. This review assesses individual study outcomes in terms of study-defined non-inferiority margin, or if no margin is specified it re-examines the evidence using the most appropriate estimate of this margin obtained from existing research of in-person CBT across many RCTs. In addition to clarifying the current state of the evidence about the relative efficacy of c/iCBT compared with in-person CBT, a secondary aim of the current review is to synthesise any evidence from the included RCTs which addresses whether the severity of the disorder moderates the relative treatment benefits of c/iCBT compared with inperson CBT. Pre-intervention symptom severity is identified as a predictor of response to CBT interventions for anxiety disorders (Turner et al., 2018) and has been suggested as a marker for beginning with a low intensity intervention such as digital CBT in stepped care models of delivery for common mental health problems (Van Straten et al., 2015) . In particular, the review examines if c/iCBT is inferior to in-person CBT for patients with severe anxiety disorders but not inferior to in-person CBT for patient with mild to moderate disorders.
Aims
This study evaluates whether CBT delivered by computer or online (c/iCBT) is not inferior to CBT in-person for reducing levels of symptoms and producing clinically significant gains at post-treatment and at follow-up for adults with anxiety disorders, PTSD or OCD. A supplementary objective of the review is to examine the evidence for severity of the disorder as a moderator of the relative efficacy of c/iCBT and in-person CBT for these disorders.
Methods

Study design and protocol
The review was undertaken using the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines (Moher et al., 2009) . A review protocol was developed and registered with Prospero International prospective register of systematic reviews (O'Kearney et al., 2018; Prospero: CRD42018096165) .
Criteria for considering eligibility
Types of studies. Randomised control trials with at least a c/ iCBT and an in-person CBT arm were included. Studies were included if they were set up to compare c/iCBT to inperson CBT regardless of whether they specify a superiority or non-inferiority of c/iCBT against CBT in-person. Studies may include additional comparators such as, waitlist, CAU or pill or psychological placebo. Any psychological placebo comparator must not include cognitive therapy or exposure strategies.
Types of participants. Adults (age ⩾ 18 years) with any anxiety disorder, PTSD or OCD as the primary diagnosis or high levels of symptoms were included with no exclusions for co-morbidity. or from treatment protocols which take a trans-diagnostic approach to fear-based disorders and have been translated to be accessible on a computer or other electronic device either off-line or via the Internet. Included trials could evaluate CBT programmes accessible online, delivered on a desktop or laptop computer or a mobile device in a local setting, for example, primary care practice or at home. c/iCBT studies include those that are completely autonomous and those which include some clinician or assistant contact with the patients either electronically via email, messaging, telephone or face-to-face as long as the primary mode of delivery for all CBT components is by computer or Internet.
Types of interventions
In-person CBT is disorder-specific CBT treatment protocols for any anxiety disorder, PTSD or OCD, or CBT protocols which take a trans-diagnostic approach to fearbased disorders in which CBT components are delivered to the patient by the therapist in person. These studies may include some use of electronic contact such as telephone or email as long as the primary mode of delivery is in person. CBT which is delivered by the therapist face-to-face but remotely via telelink, web camera or social media was not included.
Types of outcomes measures
Primary outcomes 1. Post-treatment and follow-up scores on a primary outcome measure either a disorder-specific symptom severity measure (e.g. Panic Severity Scale; YaleBrown Obsessive-Compulsive Scale) or a general distress/anxiety measure (e.g. Depression Anxiety Stress Scale; Spielberger Anxiety Inventory). 2. Post-treatment and follow-up categorical outcomes (e.g. responded; clinically significant improvement, no longer symptomatic) as defined by the study or identified in the study outcomes.
Search methods
We searched the major bibliographic databases (PubMed, PsycINFO, Embase and the Cochrane database of randomised trials) by combining terms (both MeSH terms and text words) indicative of psychological treatment, Internet delivery of psychological treatment and either SAD (social phobia, social anxiety, public-speaking anxiety), GAD (worry, generalised anxiety) or PD with or without agoraphobia (panic, PD), agoraphobia (PDA), PTSD (posttrauma disorders), ASD (acute stress) and OCD with filters for RCTs. We examined the references of earlier meta-analyses on psychological treatments for the included disorders (Andersson et al., 2014; Andrews et al., 2018a; Arnberg et al., 2014; Carlbring et al., 2018) . The deadline for the searches was 30 September 2018. We included all trials of a psychological treatment identified as CBT, CT (cognitive therapy) and BT (behaviour therapy) which had an arm where treatment is delivered via the Internet or computer and an in-person CBT arm.
Data collection
Selection of studies
Two reviewers examined identified abstracts for potential inclusion/exclusion and independently screened the full text studies for inclusion. All decisions were recorded and a PRISMA study flow diagram drawn.
Data extraction and management
Two reviewers independently extracted the following study characteristics and outcome data from included studies:
• • Methods. Reference population; recruitment method, study design (number of arms; simple or cluster randomised; crossover designs), duration, country of study, year of study; outcome reporting; superiority/ non-inferiority/equivalence design; inferiority margin (a priori; how determined). 
Risk of bias assessment
Two reviewers independently undertook risk of bias assessment for each included study using the Cochrane Collaboration risk of bias tool (The Cochrane Collaboration, 2018) modified for assessing RCTs inferring non-inferiority (Piaggio et al., 2012) . In addition to the domains of selection bias, performance bias, detection or measurement bias and reporting bias, the risk of bias assessment focused on whether the design/analysis was congruent with the study question, whether there was a priori setting of an inferiority margin, whether prior evidence was used to set the margin, whether results are reported for the analysis for ITT and perprotocol outcomes, whether the study included a test of the sensitivity of the in-person CBT and whether correct conclusions are draw from the analyses (Piaggio et al., 2012) .
Analysis and data synthesis
We report effect sizes or extracted post and follow-up outcomes to estimate between-group effect sizes on the primary outcomes for the c/iCBT against in-person CBT comparison. We report bias-corrected standardised mean difference (SMD; Hedges' g) for symptom severity outcomes and odds ratio (OR) for categorical outcomes. For studies with a non-inferiority of c/iCBT against in-person CBT hypothesis, both ITT and per-protocol effect sizes are reported when available and compared with the study identified non-inferiority margin (Δ). If no margin is specified, we used the recommendation from the Guidance Statement on Choice of Control Groups in clinical trials (International Conference on Harmonisation [ICH], 2001). These guidelines recommend that the margin should not be greater than the smallest effect size that the active treatment would be reliably expected to have compared with a credible placebo (Greene et al., 2008; Hwang and Morikawa, 1999; ICH, 2001) . We set the margin (Δ) as the lower bound of the 95% CI for the pooled effect sizes reported in the most recent high quality meta-analysis of in-person CBT compared with placebo controls for the particular anxiety disorders (SAD, PD, SP), PTSD or OCD (Carpenter et al., 2018) . Non-inferiority is established where the upper bound of the 95% CI for the effect size estimate comparing in-person to c/iCBT for an individual study is less than Δ (Althunian et al., 2017; Schumi and Wittes, 2011) . The decision to pool study between-group outcomes was based on the number of studies in a comparison and the degree of statistical heterogeneity (95% CIs for I 2 ). We also considered methodological heterogeneity between the studies particularly variability in the studies in their CBT components and degree of therapist involvement in c/iCBT. If pooling is done, random effects analyses were used and the pooled estimates and their 95% CIs were compared to the non-inferiority margin. We undertook sub-group analysis for severity if enough study outcomes were disaggregated by severity of symptoms (participants with mild and moderate versus high levels of symptoms).
Results
Search results
Figure 1 presents the PRISMA flow diagram for the study selection process and the reasons for exclusion. Reports were excluded if they were duplicates of other studies, were reviews, protocols of studies, did not have an in-person comparator, included participants below 18 years of age without disaggregation of the outcomes by age or did not report on any primary outcome. A total of 14 studies were identified for data extraction. Nine studies involved the comparison of Internet-delivered CBT (iCBT) against inperson CBT and five the comparison of computer-delivered CBT against in-person CBT. A total of 13 studies provided between-group effect sizes for a continuous outcome (severity of symptoms) and 11 for a categorical outcome (responder status). Two outputs from the same RCT (Haug et al., 2015; Nordgreen et al., 2016) reported on a categorical and a severity outcome, respectively. Table 1 presents the characteristics of the included studies. The studies reported results from 1135 participants with 885 in the Internet CBT versus in-person CBT studies (n = 458; Internet CBT) and 250 in the computer CBT versus in-person comparisons (n = 135; computer CBT). Three Internet studies examined social phobia, three PD, two combined social phobia and PD and one SP. Of the computer CBT studies, two studied SP, one agoraphobia, one OCD and one mixed phobias including agoraphobia, social and SP. One of the Internet studies included a third arm (waitlist) while all of the computer studies included a control comparator (relaxation, book, waitlist). Of the Internet studies, all except Nordgreen et al. (2016) reported on a symptom severity primary outcome and all except Andrews et al. (2011) and Haug et al. (2015) reported on a categorical primary outcome. All computer studies reported for a symptom severity primary outcome and two (Gilroy et al., 2000; Heading et al., 2001 ) also reported on a categorical primary outcome. Delivery of in-person CBT was individual in all the studies except in Hedman et al. (2011) and Bergstrom et al. (2010) where group in-person CBT was used.
Three additional reports (Andersson et al., 2008; Hedman et al., 2012; Nordgreen et al., 2016) were identified that presented data from corresponding included RCTs (Carlbring et al., 2005; Haug et al., 2015; Hedman et al., 2011 , respectively) about pre-treatment factors which may differentially predict treatment response for c/iCBT and inperson CBT.
Risk of bias of included studies
The risk of bias summary for the 14 studies is provided in Table 2 . In regard to the chief criteria for assessing noninferiority conclusions, two studies (Bergstrom et al., 2010; Hedman et al., 2011 ) established a non-inferiority hypothesis and set a non-inferiority margin prior to the data collection. Only Hedman et al. (2011) based this on evidence from in-person compared with placebo RCTs. Bergstrom's initial choice of ∆ = 0.20 was based on detecting a small effect but then changed to ∆ = 0.50 for power reasons although the study did not use either margin in their analysis. Nine studies were assessed as having high or unclear risk of bias in relationship to including a test of the sensitivity of the in-person CBT while all studies were assessed as having high or unclear risk of bias associated with insufficient analysis to test non-inferiority. Hedman et al. (2011) study was assessed as low risk of interpretation bias for inferring non-inferiority of iCBT and Ghosh et al. (1988) , Gilroy et al. (2000) , Griest et al. (2002) and Heading et al. (2001) were assessed as low risk of bias when inferring superiority of in-person CBT. All the other studies have a high or unclear risk of interpretation bias.
Relative effects of the interventions
We grouped the computer and Internet studies separately in the presentation of each primary outcome because the CBT procedures in the computer studies focused on exposure and were mostly office based while the Internet studies included a wider range of CBT procedures and were home based. In addition, as all the Internet studies had CBT protocols designed as disorder-specific, they were grouped according to disorder (SAD, PD, SP) in the presentation of the results. Figure 2 presents the forest plot for the between-group (in-person CBT -c/iCBT) effect size estimates for symptom severity at post-treatment (Hedges' g). The sign of the effect sizes have been adjusted to show the strength of the effect in favour of in-person CBT effect as positive. Figure 3 presents the forest plot for effect size estimates for the proportion of participants who were responders to treatment at post-treatment (i/cCBT/inperson CBT, OR) and the 95% CI around these estimates. All outcome data are ITT as per-protocol outcomes could not be extracted reliably from the studies. Pooled effect sizes for the sub-groups are also presented but need to be interpreted with caution because of small sample size in many studies (Lin, 2018) , small number of studies in the sub-groups, notable methodological heterogeneity within sub-groups and additional statistical heterogeneity for the SAD Internet studies.
Post-treatment outcomes.
Severity of symptoms at post-treatment.
Of the two studies which assessed outcomes against a study-justified noninferiority margin, Hedman et al. (2011) Figure 4 presents the forest plot for the between-group (in-person CBT -c/iCBT) effect size estimates for symptom severity at follow-up (SMD) and Figure 5 the forest plot for responder status at follow-up (OR) and the 95% CI around these estimates. Because consistent estimates for the effects size of in-person CBT compared with placebos at follow-up are not available, we took a conservative approach to estimating the non-inferiority margins at followup and assumed no loss of relative efficacy of in-person CBT compared with placebos from post to follow-up.
Follow-up outcomes.
Severity of symptoms at follow-up. Nine studies (Andersson et al., 2006; Bergstrom et al., 2010; Botella et al., 2010; Carlbring et al., 2005; Ghosh et al., 1988; Gilroy et al., 2000; Haug et al., 2015; Heading et al., 2001; Hedman et al., 2011) reported between-group effects for symptom severity at follow-up. Responder status at follow-up. Six studies (Andersson et al., 2006; Botella et al., 2010; Carlbring et al., 2005; Gilroy et al., 2000; Heading et al., 2001; Hedman et al., 2011) reported responder status outcome at follow-up. All except Hedman et al. (2011) , which shows a superiority for iCBT over in-person CBT, report upper bounds of the 95% CI around their OR estimates of greater than 4 (>Δ = 1.64). Table 3 presents the outcomes for the three studies which report results for moderation effects for disorder severity or co-morbidity. Each of the studies used data from a RCT to examine whether symptom severity and co-morbidity at pre-treatment differentially predicts outcome for iCBT and in-person CBT. Hedman et al. (2012) reported that higher levels of general anxiety were associated with higher social anxiety scores at post-treatment and with higher likelihood of having a diagnosis of SAD at 6-month follow-up in iCBT but did not predict response to in-person CBT. In addition, Hedman et al. (2012) reported that absence of comorbid depression is associated with better response in the iCBT group at post-treatment but not in in-person CBT. Haug et al. (2015) showed that that there is no difference between outcomes for iCBT and in-person CBT for SAD and PD patients with depression but for those without depression in-person CBT is superior to iCBT. Andersson et al. (2006) presented evidence that for PD patients more severe interference in mobility at pre-treatment predicted poorer treatment response for in-person CBT but not for iCBT while cluster C personality traits predicted a poorer response in iCBT but not in-person CBT.
Severity as a moderator of relative treatment response
Discussion
For adults with anxiety disorders, PTSD and OCD CBT delivered in person has been shown to be consistently effective compared with credible placebos (Carpenter et al., 2018; Cuijpers et al., 2016) . There has been extensive recent efforts to adapt CBT for these disorders so it can be delivered by Internet or computer to increase access, reduce costs and improve acceptability and the fidelity of delivery. This study examined the evidence from RCTs addressing whether the benefits in symptom reduction and clinically significant gains from CBT delivered by computer and online (c/iCBT) are not inferior to those of CBT in-person.
There are two general conclusions from the current review. First, the vast majority of studies from which non-inferiority or equivalence has been inferred have not been properly designed to establish such conclusions. One study (Hedman et al., 2011) showed low risk of bias as a non-inferiority trial while all other studies were not consistent with the recommended CONSORT criteria (Piaggio et al., 2012) . Most critically, these studies did not establish a proper non-inferiority hypothesis and did not set a noninferiority margin. Their conclusions often repeat the widespread problem (Altman and Bland, 1995; Greene et al., 2000) of misinterpreting a failure to reject a null hypothesis as evidence of equivalence or non-inferiority. Second, the results of 12 out of 13 studies for symptom severity at posttreatment and of 11 out of 13 for responder status at posttreatment do not support a conclusion of non-inferiority when the effect size estimates from the studies are tested against the established lowest estimate of the true effects of in-person CBT against credible placebos (Carpenter et al., 2018) . Hedman et al. (2011) found superiority and noninferiority of iCBT for symptom severity and responder status at post-treatment for SAD while Carlbring et al. (2005) found evidence of non-inferiority of iCBT for PD for responder status at post-treatment. Hedman et al. (2011) for SAD and Bergstrom et al. (2010) for PD reported evidence supporting non-inferiority of iCBT at follow-up. None of the pooled estimates for the computer-delivered studies and for Internet studies for SAD and PD support a conclusion of non-inferiority. It is important to note that the effects for some studies and for the pooled effects for the in-person CBT compared with computer delivery studies indicate that in-person CBT has superior benefits. These conclusions strongly indicate that, based on evidence from head-to-head RCTs, it is premature to suggest that the treatment effects of CBT for anxiety disorders delivered by Internet or computer are equivalent to or not less than those of therapist-delivered CBT, or that Internet CBT with minimal therapist contact is an equivalent firstline treatment to in-person CBT (Andersson et al., 2014; Andrews et al., 2018a Andrews et al., , 2018b Carlbring et al., 2018) . As Internet delivery in particular offers attractive advantages in terms of dissemination, access and cost, it is very important to properly assess the extent of any treatment benefits which may be given up in using the new mode of delivery relative to in-person CBT. Our review indicates that with one exception (Hedman et al., 2011) , this has not been addressed in properly conducted non-inferiority RCTs of CBT for anxiety disorders, PTSD or OCD. The need for these studies in regard to Internet CBT is further underlined by the rapid expansion of applications aimed at translating CBT to digital platforms in the absence of a regulatory framework for ensuring quality and protecting consumers.
The studies identified for our analysis were of Internet CBT which involved none or minimal therapist guidance and computer CBT which used intensive exposure in a few sessions. Internet CBT ranged from 6 to 15 modules with therapist involvement ranging from none to minimal (therapist feedback by email; 10 minutes by phone after each module or a single psychoeducation session). Modules included a variety of CBT components focusing on psychoeducation and instructions in exposure and cognitive therapy while computer-delivered CBT were usually intensive exposure focused treatments of one to three sessions. There has been a recent increase in studies which report on blended Internet CBT and in-person delivery which while predominantly digitally delivered involve significantly more therapist input than the studies included in the current review. As far as we are aware, none of these have been RCTs which compared a more blended mode of delivery with traditional in-person CBT for anxiety disorders. The overall conclusions from the review are also restricted by the features of the included studies. Most of the evidence comes from studies of patients with social anxiety, PD and SP. We identified only one study of OCD patients using computer delivery and none for PTSD or GAD. Two studies which showed non-inferiority (Bergstrom et al., 2010; Hedman et al., 2011) used group in-person CBT and one (Carlbring et al., 2005) used individual in-person CBT.
We identified three studies which provide evidence from RCTs about factors which may predict a differential treatment response to in-person compared with Internet-or computer-delivered CBT. Hedman et al. (2012) findings are consistent with the suggestion that pre-treatment disorder severity and co-morbidity may predict a poorer outcome in iCBT but findings from Haug et al. (2015) with regard to co-morbid depression and Andersson et al. (2006) for higher functional impairment are not consistent with this suggestion. Higher level of cluster C personality traits were associated with poorer treatment outcome in iCBT but not in-person CBT (Andersson et.al. 2008) . These data are difficult to integrate and suggest considerable additional work is required to provide more confidence about inferring for which patients with anxiety disorders Internet CBT should be recommended when in-person CBT is available. Given the small number of studies and their small samples, the most productive direction for this work might be by merging person level data from existing studies which have compared in-person CBT to Internet CBT rather than using aggregated data in meta-regression. As attempts to use technologies in psychological treatments increase, providing high quality evidence about factors which may moderate the relative efficacy of in-person CBT and the new modes of delivering CBT is of critical importance to optimise outcomes for individuals and maximise the overall effectiveness of the health care system.
There are a number of potential limitations and caveats which are important in assessing the review's conclusions. First, only head-to-head comparisons were included in the review because these are the most direct tests with the highest validity for drawing inferences about relative efficacy. We acknowledge that there are other RCTs of digitally delivered CBT for anxiety disorders which support its efficacy relative to waitlist and treat-as-usual comparators. Indirect comparisons of these effects to results of similar in-person CBT studies, however, have limited utility for inferring non-inferiority or equivalence because it is not possible to estimate the impact of variations in how the trials were implemented on possible real differences in the efficacy of the two modes of delivery. Second, because only one study properly specified a non-inferiority margin, our statistical tests of the evidence for noninferiority are post hoc and may introduce bias. We offset the potential bias of post hoc analysis by using a strongly empirical approach to setting the margins based on formal statistical considerations using evidence about the consistent performance of in-person CBT against credible placebos. This is the recommended approach (ICH, 2000; Schumi and Wittes, 2011) and the margins used can be easily verified (Carpenter et al., 2018) . We compensated for the conservative nature of this approach by using the larger of the relevant disorder-specific estimates and by not reducing this margin further by applying the preserved fraction as is often recommended (Althunian et al., 2017) . The risks in using the margins adopted here include problems in the constancy of the effect as the efficacy of inperson CBT measured in RCTs has decreased over time, the limited precision in the pooled OR estimates from the Carpenter et al. (2018) study and the lack of provision for quantifying the benefits attributable to the new mode of delivery. It is arguable that because of the benefits digitally delivered CBT provides in terms of cost, access and ease of use, it is reasonable to accept a larger non-inferiority margin. It is important, however, for researchers to be aware that in making this decision that there needs to be a compelling clinical rationale provided supported by the evidence of the strengths of these advantages. At the same time, our review highlights the lack of a proper rationale for inferring non-inferiority in most of the headto-head trials as well as the challenges of future studies aimed at evaluating the efficacy of new modes of delivery of CBT. Other limitations to the review come from the features of the studies included in the review. As noted above, there are limitations to conclusions because of the small range of disorders studied, the small sample sizes, the exclusion of Internet and computer CBT which had more than minimal clinician assistance, variability in the type of in-person CBT which includes group and individual delivery and lack of a consistent way of defining responder status in the included studies.
Overall, this review shows that the current best evidence does not support claims that CBT for anxiety disorders adapted to be delivered by Internet or computer is not inferior to in-person delivery. At best, the evidence from RCTs is inconclusive in regard to whether these modes of delivery are 'equally beneficial' (Andrews et al., 2018b) because only one properly designed study has been conducted. It is recommended that future studies improve the rigour of the evaluation of Internet-or computer-delivered CBT compared with in-person CBT for anxiety disorders because establishing non-inferiority of a new treatment or mode of treatment delivery helps clinicians and policy makers ensure that a less efficacious treatment is not accepted as the standard of care.
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